Narcolepsy Treatment Market: Narcolepsy is a deep rooted resting jumble which makes you to feel gigantically worn out in some cases with wild sudden rest assaults in extreme cases. It is an inability condition which is described by three unique manifestations, for example, exorbitant daytime cataplexy, sluggishness and overpowering rest scenes, fluctuating programmed practices. Narcolepsy for the most part starts between 15 to 25 years and it can be apparent at any age. Narcolepsy is untreated and undiscovered as a rule.
Variables that are driving the development of narcolepsy treatment showcase are developing pervasiveness of different dozing issue including narcolepsy, increment in mindfulness about the rest issue. Moreover, expanding interest for cutting edge diagnostics and therapeutics to treat resting scatters and ascend in geriatric populace. Narcoleptic issue is proportionately common to Parkinson’s sickness, as indicated by the WHO insights, more than 3 million individuals are enduring with narcolepsy over the globe. Be that as it may, stringent administrative system, ignorance about the confusion in immature nations, manhandle utilization of the medications, postponed or undiscovered of the narcolepsy are the few variables which are hampering the development of narcolepsy treatment advertise.
A sample of this report is available upon request @
The narcolepsy treatment market is classified on the basis of disorder, drug class, distribution channel, and geography.
Based on type of disorder, the narcolepsy treatment market is segmented into the following:
- Secondary Narcolepsy
- Narcolepsy with cataplexy
- Narcolepsy without cataplexy
Based on drugs, the narcolepsy treatment market is segmented into the following:
- Amphetamines
- Methylphenidate
- Modafinil
- MAO-B Inhibitors (Selegiline)
- Tricyclic Anti-Depressants (TCA)
- Selective Serotonin Reuptake Inhibitors (SSRI)
- Monoamino Oxidase Type-A (MAO-A) inhibitors
Based on distribution channel, the Narcolepsy Treatment Market is segmented into the following:
- Hospital pharmacies
- Retail Pharmacies
- Online Pharmacies
To view TOC of this report is available upon request @
Narcolepsy is the 3rd most common sleeping disorder which affects large group of population. Prevalence rate of narcolepsy is substantially lower in Israel i.e. 1 in 500,000 people and considerably high in Japan i.e. 1 in 600 in comparison with U.S. according to the narcolepsy network. Narcolepsy is not curable but can be treated with drugs like dextroamphetamine, methylphenidate etc. to reduce the sleep attacks. Mergers and acquisitions, collaborations, expansions to untapped geographies are the growth strategies that are adopted by the market players to enhance the market growth and to improve their product portfolio. Several voluntary organizations across the world such as Wake up Narcolepsy, Narcolepsy Network, American Sleep Association, and European Narcolepsy Network are actively involving in spreading the awareness regarding the sleeping disorders and their associated symptoms like EDS, sleep paralysis, and cataplexy.
Need more information about this report @
On the basis of geographical regions, Narcolepsy Treatment Market is classified as into five key regions as Asia- Pacific, North America, Europe, Middle East & Africa and Latin America. Europe narcolepsy treatment market is growing at significant rate owing to the high prevalence of narcolepsy disorder, increasing capital investments and established healthcare infrastructure existence associated with large population target. As per to the estimated data by Narcolepsy UK around 25,000 people are suffering with narcolepsy disorder and about 75% of people are untreated because of undiagnosed and misdiagnosed in U.K. North America holds a significant market share in narcoleptic treatment market owing to the increasing prevalence of the narcolepsy. According to Narcolepsy Network, approximately 1 in 2,000 people in U.S. are suffering with narcolepsy and prevalence of the disorder in North America is about 0.07% and incidence for narcolepsy without cataplexy is 1.37% in 100,000 people and with cataplexy are 0.74 % in 100 people.
Some of the players in narcolepsy treatment market are Arena Pharmaceuticals, Inc.(U.S), Inc., BIOPROJET, Evotec AG (Germany), Graymark Healthcare, Inc. (U.S), Hypnion, Inc. (U.S), Ligand Pharmaceuticals, Inc.(U.S), Teva Pharmaceutical Industries Ltd.(Israel) and Jazz Pharmaceuticals, Inc.,(Ireland).
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-narcolepsy-treatment-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
Media Contact
Company Name: Precision Business Insights
Contact Person: Rajesh K
Email: Send Email
Phone: 8665981553
Address:Kemp House, 152 – 160 City Road London EC1V 2NX
City: London
State: GB
Country: United Kingdom
Website: https://www.precisionbusinessinsights.com